Table I.
Certainty assessment | |||||||||
---|---|---|---|---|---|---|---|---|---|
Nr studies | Study design | Risk of bias | Inconsistency | Indirectness | Imprecision | Other considerations | Impact | Certainty | |
Activity and Participation (follow up: range 3 weeks to 15 months) | |||||||||
2/6a | Randomised trials and observational study designs | not serious | not serious | not serious | not serious | all plausible residual confounding would suggest spurious effect, while no effect was observedi | RCTs: Koopman et al. (3) and Murray et al. (4): Consistency in methods, interventions and outcomes (e.g. 6MWT, 2MWT, TUG), CIs considered not wide, homogenous. Observational: Bertelsen et al. (28), Brogardh et al. (46), Da Silva et al. (37), Davidson et al. (29), Sharma et al. (32), Skough et al. (38), Willen et al. (8): Some consistency in methods and activity outcomes. Interventions varied: strengthening, CV fitness, mixed, CIs considered not wide, homogenous. |
RCT only: ⊗⊗⊗⊗ HIGH All study designs: ⊗◯◯◯ VERY LOW |
|
Body function mental and sensory (follow up: range 4 weeks to 10 months) | |||||||||
3/5 | randomised trials and observational study designs | seriousc
very seriousb,c |
not serious seriousd |
not serious seriousg |
not serious serioush |
all plausible residual confounding would suggest spurious effect, while no effect was observedi | RCTs: Koopman et al. (3), Oncu et al. (48) and Murray et al. (4) some consistency in methods, interventions and outcomes (e.g. all fatigue), CIs considered not wide Observational: Bertelsen et al. (28), Da Silva et al. (37), Davidson et al. (29), Dean et al. (25), Sharma et al. (32): Varied effect, CIs not wide, apparent improvement, interventions similar but outcomes varied. |
RCT only: ⊗⊗⊗◯ MODERATE All study designs: ⊗◯◯◯ VERY LOW |
|
Body function lower (follow up: range 16 weeks to 10 months) | |||||||||
2/9 | randomised trials and observational study designs | very seriousb,c |
seriousd | not serious | serioush | publication bias strongly suspected, all plausible residual confounding would suggest spurious effect, while no effect was observedi | Jones et al. (47), Koopman et al. (3): Varied effect, wide CIs, apparent improvement, similar study characteristics (methods, interventions and outcomes). | All study designs: ⊗◯◯◯ VERY LOW |
|
Body function cardiovascular (follow up: range 8 weeks to 10 months) | |||||||||
4/2 | randomised trials and observational study designs | very seriousb,c | seriousd | seriousf,g | serioush | all plausible residual confounding would suggest spurious effect, while no effect was observedi | Jones et al. (47), Kriz et al. (26), Koopman et al. (3), Oncu et al. (48): Varied effect, wide CIs, apparent improvement. | All study designs: ⊗◯◯◯ VERY LOW |
|
Body function non-lower (follow up: range 4 weeks to 16 weeks) | |||||||||
3/2 | randomised trials and observational study design | very seriousb,c,d | seriouse | seriousf,g | serioush | all plausible residual confounding would suggest spurious effect, while no effect was observedi | Murray et al. (4), Chan et al. (33), Kriz et al. (26): Varied effect, wide CIs, apparent improvement. |
All study designs: ⊗◯◯◯ VERY LOW |
indicates ratio of RCT to non-RCT studies. CI: Confidence interval, CV: Cardiovascular fitness, RCT: randomised controlled trials, TUG: Timed up and go test, 6MWT: Six min walk test, 2MWT: Two min walk test Explanations:
no measure of random variability
limited adjustment of confounding
limited loss to followup, no intention to treat analysis
substantial heterogeneity
Differences in diagnostic criteria
Differences in outcome measures
Wide Confidence Intervals
as identified via funnel plot